RW Effectiveness of Lurbinectedin in Extensive Stage SCLC

Clinical trial NCT05285033 · COMPLETED

Trial details

NCT number: NCT05285033
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Status: COMPLETED
Study type: OBSERVATIONAL

Small-cell Lung Cancer

Start date: 2022-04-01
Primary completion: 2022-12-15
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.